Department of Anesthesiology and Pain Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
JAMA Otolaryngol Head Neck Surg. 2019 Feb 1;145(2):117-123. doi: 10.1001/jamaoto.2018.3097.
Emergence agitation is common after nasal surgery under general anesthesia and may lead to serious consequences for the patient, including an increased risk of injury, pain, hemorrhage, and self-extubation. Despite decades of research, studies on the incidence, risk factors, and prevention of emergence agitation in adult patients are ongoing, and opinions differ on the different effects of inhalation and intravenous anesthesia.
To investigate the effect of anesthetic method on the occurrence of emergence agitation after nasal surgery.
DESIGN, SETTING, AND PARTICIPANTS: This prospective, randomized, single-blind, clinical trial included 80 patients undergoing open rhinoplasty, septoplasty, turbinoplasty, endoscopic sinus surgery, and functional endoscopic sinus surgery under general anesthesia who were randomized to receive total intravenous anesthesia (TIVA) with remifentanil hydrochloride and propofol (n = 40) or volatile induction and maintenance of anesthesia (VIMA) with sevoflurane and nitrous oxide (n = 40) in Asan Medical Center, a tertiary referral center in Seoul, Republic of Korea. Data were collected from August 24 through October 14, 2016, and analyzed from October 26, 2016, through September 14, 2017.
The occurrence of emergence agitation defined by the following 2 individual criteria: a Richmond Agitation-Sedation Scale score of at least 1 and a Riker Sedation-Agitation Scale score of at least 5 immediately after extubation.
Among the 80 patients included in the analysis (68.8% men [n = 55]; mean [SD] age, 41.6 [17.9] years), emergence agitation measured by the Richmond Agitation Sedation Scale occurred in 8 of 40 patients (20.0%) in the VIMA group and 1 of 40 (2.5%) in the TIVA group. The risk difference was 17.5 (95% CI, 3.6-31.4). Emergence agitation measured by the Riker Sedation-Agitation Scale score occurred in 10 of 40 patients (25.0%) in the VIMA group and 1 of 40 (2.5%) in the TIVA group. The risk difference was 22.5 (95% CI, 7.3-37.7).
The occurrence of emergence agitation after nasal surgery under general anesthesia can be significantly reduced by using TIVA rather than VIMA.
CRIS identifier: KCT0002145.
全身麻醉下进行鼻手术后出现苏醒期躁动较为常见,这可能会给患者带来严重后果,包括增加受伤、疼痛、出血和自行拔管的风险。尽管已有数十年的研究,但成人患者苏醒期躁动的发生率、危险因素和预防措施仍在研究中,对于吸入和静脉麻醉的不同效果,不同观点仍存在分歧。
探究不同麻醉方式对鼻手术后苏醒期躁动发生的影响。
设计、设置和参与者:本前瞻性、随机、单盲、临床试验纳入了 2016 年 8 月 24 日至 10 月 14 日在韩国首尔的 Asan 医疗中心接受全身麻醉下开放性鼻整形术、鼻中隔成形术、鼻甲切除术、内镜鼻窦手术和功能性内镜鼻窦手术的 80 例患者,患者被随机分为接受盐酸瑞芬太尼和丙泊酚的全凭静脉麻醉(TIVA)组(n = 40)或七氟醚和氧化亚氮挥发性诱导和维持麻醉(VIMA)组(n = 40)。数据于 2016 年 10 月 26 日收集,并于 2017 年 9 月 14 日分析。
使用以下 2 项个体标准定义苏醒期躁动的发生:拔管后即刻 Richmond 躁动-镇静量表评分至少 1 分和 Riker 镇静-躁动量表评分至少 5 分。
在纳入的 80 例患者(68.8%为男性[ n = 55];平均[标准差]年龄为 41.6[17.9]岁)中,VIMA 组有 8 例(20.0%)患者和 TIVA 组有 1 例(2.5%)患者的苏醒期躁动通过 Richmond 躁动镇静量表测量。风险差异为 17.5(95%置信区间,3.6-31.4)。VIMA 组有 10 例(25.0%)患者和 TIVA 组有 1 例(2.5%)患者的苏醒期躁动通过 Riker 镇静-躁动量表评分测量。风险差异为 22.5(95%置信区间,7.3-37.7)。
全身麻醉下进行鼻手术后,使用 TIVA 而非 VIMA 可显著降低苏醒期躁动的发生。
CRIS 标识符:KCT0002145。